NATURETIN-10 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Naturetin-10, and what generic alternatives are available?
Naturetin-10 is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in NATURETIN-10 is bendroflumethiazide. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NATURETIN-10?
- What are the global sales for NATURETIN-10?
- What is Average Wholesale Price for NATURETIN-10?
Summary for NATURETIN-10
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Patent Applications: | 3,862 |
DailyMed Link: | NATURETIN-10 at DailyMed |
US Patents and Regulatory Information for NATURETIN-10
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | NATURETIN-10 | bendroflumethiazide | TABLET;ORAL | 012164-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |